Pneumonia due to Mycoplasma pneumoniae is common, but it is rarely life-threatening. A case is reported in a previously healthy adult whose illness was severe enough to require treatment with intermittent positive pressure ventilation (IPPV) for 14 days and which resolved after treatment with corticosteroids. 
Summary
Pneumonia due to Mycoplasma pneumoniae is common, but it is rarely life-threatening. A case is reported in a previously healthy adult whose illness was severe enough to require treatment with intermittent positive pressure ventilation (IPPV) for 14 days and which resolved after treatment with corticosteroids. On the fifth day after admission IPPV was temporarily discontinued, but spontaneous ventilation was still inadequate, Po2 5-6 kPa (42 mmHg) and a tracheostomy was performed. Despite continued ventilation with high inflation pressures up to 40ml H2O, the Pco2 remained elevated at 66 kPa (50 mmHg). On day 14 treatment with hydrocortisone 200 mg 6-hourly was started. Clinical improvement occurred promptly and by day 16 the inflation pressures had fallen to 10 ml H20 and the Pco2 to 3-3 kPa (24 mmHg). Forty-eight hours later it was possible to discontinue IPPV. Prednisolone 100mg daily was substituted for the hydrocortisone and reduced in dosage over the following 4 weeks. The patient's further recovery was uneventful. She was discharged home 7 weeks after admission when the sputum was clear and a full blood count was normal. Four weeks later she was asymptomatic and a chest X-ray still showed some basal shadowing.
Discussion
Mycoplasma pneumoniae infection of such severity is rarely seen in otherwise healthy patients, although Foy et al. (1973) described 4 serious cases in patients with immunodeficiency. There was no evidence of immunodeficiency in this patient; the raised IgM and low complement levels were compatible with an acute infection associated with immune complex formation. Secondary bacterial infection was unlikely in view of the persistently negative blood and sputum cultures. She improved eventually when corticosteroid treatment was started. Such a response has been reported previously (Holt, Ryan and Epstein, 1977; Noreiga et al., 1974) , and is probably due to a resolution of the inflammatory alveolar reaction. Noreiga et al. postulate that steroids may be useful in containing the immunological response to mycoplasmal antigens by inhibiting the cellular immune mechanisms and thereby preventing tissue damage resulting from this host response. This experience supports previous impressions that corticosteroids are of value in promoting resolution in severe M. pneumoniae pneumonia.
